下一个

自动播放

GRACEcast-084_Lung-Cancer_ALK Inhibition: Science and Early Clinical Experience by Dr. Ben Solomon

6 意见 • 07/30/23
分享
嵌入
administrator
administrator
订户
0

http://cancergrace.org/

Dr. Ben Solomon of Peter MacCallum Cancer Centre in Melbourne Australia reviews ALK Inhibition from mechanism of action to activity and side effect profile of crizotinib, newly approved for patients with ALK-positive advanced non-small cell lung cancer.

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放